Injection of Mesenchymal Stem Cells as a Supplementary Strategy of Marrow Stimulation Improves Cartilage Regeneration After Lateral Sliding Calcaneal Osteotomy for Varus Ankle Osteoarthritis: Clinical and Second-Look Arthroscopic Results
- PMID: 26993668
- DOI: 10.1016/j.arthro.2016.01.020
Injection of Mesenchymal Stem Cells as a Supplementary Strategy of Marrow Stimulation Improves Cartilage Regeneration After Lateral Sliding Calcaneal Osteotomy for Varus Ankle Osteoarthritis: Clinical and Second-Look Arthroscopic Results
Abstract
Purpose: To compare the clinical and second-look arthroscopic outcomes in patients undergoing arthroscopic marrow stimulation combined with lateral sliding calcaneal osteotomy for varus ankle osteoarthritis, with or without adipose-derived mesenchymal stem cell (MSC) injection.
Methods: In this retrospective comparative study, 49 patients with varus ankle osteoarthritis underwent second-look arthroscopy after arthroscopic marrow stimulation combined with lateral sliding calcaneal osteotomy between January 2010 and November 2012; 23 ankles underwent marrow stimulation alone (group 1), and 26 underwent marrow stimulation with MSC injection (group 2). The decision whether to receive the MSC injection, which was free of charge, was solely up to the patients. Second-look arthroscopies were performed at a mean of 12.5 months and 12.4 months postoperatively in group 1 and group 2, respectively. Clinical outcome measures included a visual analog scale (VAS) score for pain and the American Orthopaedic Foot & Ankle Society (AOFAS) score. The radiologic outcome variable was the talar tilt angle. On second-look arthroscopy, cartilage regeneration was evaluated using the International Cartilage Repair Society (ICRS) grade.
Results: The mean VAS score improved significantly from 7.3 ± 0.9 to 3.9 ± 1.2 in group 1 and from 7.4 ± 0.8 to 3.1 ± 1.5 in group 2 at final follow-up (P < .001 for both groups). The mean AOFAS score also improved significantly from 64.4 ± 4.1 to 79.6 ± 7.7 in group 1 and from 63.5 ± 4.2 to 84.2 ± 7.9 in group 2 at final follow-up (P < .001 for both groups). The VAS and AOFAS scores were significantly better in group 2 than in group 1 (P = .040 and P = .047, respectively). ICRS grades were significantly correlated with clinical outcomes in both groups (all P < .05), and there were significant differences in ICRS grades between the groups (P < .05). The mean talar tilt angle improved significantly after lateral sliding calcaneal osteotomy in both groups and was significantly correlated with clinical outcomes and ICRS grade (all P < .05).
Conclusions: In patients with varus ankle osteoarthritis who underwent lateral sliding calcaneal osteotomy, significant improvements in VAS and AOFAS scores, as well as better ICRS grades, were achieved at short-term follow-up after marrow stimulation with additional MSC injection compared with after marrow stimulation alone.
Level of evidence: Level III, retrospective comparative study.
Copyright © 2016 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.
Comment in
-
Editorial Commentary: Precise Nomenclature Is Critical for Evaluating Progress in the Field of Lipoaspirate-Derived Stem Cell Therapy.Arthroscopy. 2016 May;32(5):890-1. doi: 10.1016/j.arthro.2016.03.001. Arthroscopy. 2016. PMID: 27151452
Similar articles
-
Supramalleolar Osteotomy With Bone Marrow Stimulation for Varus Ankle Osteoarthritis: Clinical Results and Second-Look Arthroscopic Evaluation.Am J Sports Med. 2014 Jul;42(7):1558-66. doi: 10.1177/0363546514530669. Epub 2014 Apr 25. Am J Sports Med. 2014. PMID: 24769408
-
Additional mesenchymal stem cell injection improves the outcomes of marrow stimulation combined with supramalleolar osteotomy in varus ankle osteoarthritis: short-term clinical results with second-look arthroscopic evaluation.J Exp Orthop. 2016 Dec;3(1):12. doi: 10.1186/s40634-016-0048-2. Epub 2016 May 20. J Exp Orthop. 2016. PMID: 27206975 Free PMC article.
-
Comparative Matched-Pair Analysis of Open-Wedge High Tibial Osteotomy With Versus Without an Injection of Adipose-Derived Mesenchymal Stem Cells for Varus Knee Osteoarthritis: Clinical and Second-Look Arthroscopic Results.Am J Sports Med. 2018 Sep;46(11):2669-2677. doi: 10.1177/0363546518785973. Epub 2018 Aug 6. Am J Sports Med. 2018. PMID: 30080423
-
Supramalleolar Osteotomy With Distraction Arthroplasty in Treatment of Varus Ankle Osteoarthritis With Large Talar Tilt Angle: A Case Report and Literature Review.J Foot Ankle Surg. 2017 Sep-Oct;56(5):1125-1128. doi: 10.1053/j.jfas.2017.04.022. Epub 2017 May 27. J Foot Ankle Surg. 2017. PMID: 28558996 Review.
-
Efficacy of supramalleolar osteotomy in the treatment of traumatic ankle joint varus deformity in adolescents.J Orthop Surg Res. 2023 Oct 4;18(1):749. doi: 10.1186/s13018-023-04239-w. J Orthop Surg Res. 2023. PMID: 37789419 Free PMC article. Review.
Cited by
-
Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis.Knee Surg Sports Traumatol Arthrosc. 2018 Nov;26(11):3499-3507. doi: 10.1007/s00167-018-4955-x. Epub 2018 Apr 30. Knee Surg Sports Traumatol Arthrosc. 2018. PMID: 29713784
-
Contemporary Review: The Use of Adipocyte-Derived Mesenchymal Stem Cells in Pathologies of the Foot and Ankle.Foot Ankle Orthop. 2023 Nov 2;8(4):24730114231207643. doi: 10.1177/24730114231207643. eCollection 2023 Oct. Foot Ankle Orthop. 2023. PMID: 37929076 Free PMC article. Review. No abstract available.
-
Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus.J Vis Exp. 2018 Jan 23;(131):56395. doi: 10.3791/56395. J Vis Exp. 2018. PMID: 29443020 Free PMC article.
-
Mesenchymal Stromal Cell-Based Therapy-An Alternative to Arthroplasty for the Treatment of Osteoarthritis? A State of the Art Review of Clinical Trials.J Clin Med. 2020 Jun 30;9(7):2062. doi: 10.3390/jcm9072062. J Clin Med. 2020. PMID: 32630066 Free PMC article. Review.
-
Effectiveness of Stromal Vascular Fraction (SVF) and Platelet-Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Protocol for a Phase 3, Prospective, Randomized, Controlled, Multicenter Study (SPOST Study).JMIR Res Protoc. 2025 Apr 8;14:e62659. doi: 10.2196/62659. JMIR Res Protoc. 2025. PMID: 40198111 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials